Application of flavin-dependent halogenase

By discovering and identifying flavin-dependent halogenase genes, we have achieved bromination catalysis of a variety of natural polyphenols, solving the problem of the lack of efficient catalysis for the bromination of polyphenols in existing technologies and providing a catalytic solution with wide applications.

CN119020305AActive Publication Date: 2024-11-26HUBEI UNIV

Patent Information

Application Number
CN202310605174.X
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2023-05-23
Publication Date
2024-11-26
Estimated Expiration
2043-05-23

AI Technical Summary

Technical Problem

Existing technologies lack flavin-dependent halogenases that can efficiently catalyze the bromination of polyphenolic compounds, especially bromination reactions, which have few research reports. Traditional chemical methods suffer from byproduct toxicity and regioselectivity issues.

Method used

The flavin-dependent halogenase genes derived from Alternaria maculatae and Alkalophila spp. were discovered and identified. Recombinant plasmids were constructed and expressed in host cells, enabling the bromination catalysis of natural polyphenols, including stilbene, flavonoids and lignans, through the synergistic action of flavin and flavin reductase.

Benefits of technology

We provide flavin-dependent halogenases with a broad substrate spectrum and excellent bromination catalytic activity, which can efficiently catalyze the bromination of a variety of natural polyphenolic compounds to generate brominated products with various application potentials, applicable to fields such as medicine, agriculture, water treatment, disinfection, electronics, construction, and automobiles.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure HDA0004250442310000011
    Figure HDA0004250442310000011
  • Figure HDA0004250442310000012
    Figure HDA0004250442310000012
  • Figure HDA0004250442310000021
    Figure HDA0004250442310000021
Patent Text Reader

Abstract

The invention relates to application of flavin-dependent halogenase, and particularly discloses application of the following protein or an expression vector containing a nucleotide sequence for encoding the protein or a host cell capable of expressing the following protein in catalysis of bromination of natural polyphenol compounds. The protein is (a) the protein shown in any amino acid sequence in SEQ ID No.1-3, and (b) the protein shown in any amino acid sequence in SEQ ID No.2-3; or (b) a protein which is formed by substitution, deletion or addition of one or more amino acid residues of any amino acid in SEQ ID No.1-3 and has the function of the protein in (a). The compound has wide activity on natural polyphenol compounds; the catalytic bromination activity is excellent.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the field of biotechnology, and in particular to the use of a protein having flavin-dependent halogenase activity, an expression vector containing a gene encoding the protein, and a genetically engineered bacterium capable of expressing the protein in catalyzing the bromination of natural polyphenol compounds. Background Art

[0002] Halides play an important role in medicine and agriculture, and are also essential intermediates in many synthetic routes. The introduction of halogen substituents into organic compounds has a significant impact on their biological activity. Traditional chemical halogenation methods have various drawbacks, such as the generation of toxic byproducts, lack of regioselectivity or special requirements for substrates. Enzymatic halogenation has become a favorable synthetic method in synthetic chemistry. Halogenases as biocatalysts can be used for the modification of some molecular structures, the later functionalization of complex molecules, and can also be combined with chemical catalysts.

[0003] Among different types of halogenases, flavin-dependent halogenases have attracted extensive attention and research as relatively promising halogenases. However, so far, the research reports on flavin-dependent halogenases are mainly tryptophan halogenases, and they mainly perform chlorination reactions. There are no research reports on bromination of polyphenol compounds.

[0004] Natural polyphenol compounds are secondary metabolites of plants, and fruits, vegetables, and grains contain a large amount of polyphenols. Brominated polyphenol compounds can have a variety of effects, depending on their structure and application areas. For example, studies have shown that 4'-bromo-resveratrol may contribute to the targeted treatment of gastric cancer stem cells. Some brominated polyphenol compounds can be used as broad-spectrum antimicrobial agents that can kill many types of bacteria, fungi, and viruses. These compounds are widely used in water treatment, disinfection, medical treatment, and agriculture. Brominated polyphenol compounds can also be used as flame retardants to improve the combustion performance of combustible materials. These compounds are widely used in electronics, construction, and automobiles. Some brominated polyphenol compounds are used as drugs to treat certain diseases, such as cancer and heart disease. Brominated polyphenol compounds can be used as preservatives to extend the shelf life of food, wood, and textiles; they can also be used to prepare polymers, resins, coatings, and dyes for process manufacturing. In addition, brominated polyphenol compounds can also be used as intermediates to introduce other groups through cross-coupling reactions to synthesize other valuable compounds. However, so far, no brominase that can catalyze polyphenol compounds has been reported.

[0005] Therefore, it is of great significance to explore flavin-dependent brominases with excellent performance and use them to catalyze the bromination of polyphenolic compounds for the research expansion in this field. Summary of the invention

[0006] The purpose of the present invention is to provide a flavin-dependent halogenase for use in catalyzing the bromination of natural polyphenolic compounds. The flavin-dependent halogenase has a wide range of activities on natural polyphenolic compounds and has excellent catalytic bromination activity.

[0007] To achieve the above technical objectives, the inventors conducted a large number of experiments and unremitting explorations to explore flavin-dependent halogenases in bacteria from many different sources. After candidate gene cloning, heterologous expression, and catalytic activity analysis, they finally discovered, identified, and screened three flavin-dependent halogenase genes with catalytic bromination activity of natural polyphenol compounds. Based on this, the following technical solution was finally obtained:

[0008] The present invention provides the use of the following protein or an expression vector comprising a nucleotide sequence encoding the protein or a host cell capable of expressing the following protein in catalyzing the bromination of natural polyphenol compounds. The protein is: (a) a protein as described in any one of the amino acid sequences in SEQ ID No. 1-3, or (b) a protein having the function of the protein described in (a) formed by replacing, deleting or adding one or more amino acid residues in any one of the amino acids in SEQ ID No. 1-3.

[0009] According to the above scheme, the host cells include but are not limited to Escherichia coli (E. coli), Corynebacterium glutamicum (Corynebacterium glutamicum), Bacillus subtilis (Bacillus subtilis), Saccharomyces cerevisiae (Saccharomyces cerevisiae), Aspergillus oryzae (Aspergillus oryzae).

[0010] According to the above scheme, the natural polyphenol compounds include stilbenes, flavonoids, lignans and other natural polyphenol compounds.

[0011] According to the above scheme, the natural polyphenol compounds include but are not limited to sesamin, piceatannol, resveratrol, quercetin, naringenin, epicatechin, apigenin, and daidzein.

[0012] According to the above scheme, when the natural polyphenol compound is trans-resveratrol, the protein (AmFDH5) shown in SEQ ID No.1 catalyzes the bromination of trans-resveratrol to produce 4-bromo-resveratrol and 3'-bromo-resveratrol, and the protein (LaFDH2) shown in SEQ ID No.2 or the protein (LaFDH4) shown in SEQ ID No.3 catalyzes the bromination of resveratrol to produce 4-bromo-resveratrol.

[0013] When the catalytic bromination substrate is sesamin, piceatannol, resveratrol, quercetin, naringenin, epicatechin, apigenin, and daidzein, the catalytic bromination reaction products are brominated sesamin, brominated piceatannol, brominated resveratrol, brominated quercetin, brominated naringenin, brominated epicatechin, brominated apigenin, and brominated daidzein.

[0014] According to the above scheme, a tag sequence is added to the end of the amino acid sequence of the protein shown in (a) or (b) and has the function of the protein described in (a). The tag can be specifically selected from His tag, MBP tag, sumo tag, etc.

[0015] According to the above scheme, the application method is: in the presence of flavin and flavin reductase, catalyzing the bromination of natural polyphenol compounds to synthesize brominated natural polyphenol compounds.

[0016] The advancement and advantages of the present invention are:

[0017] The present invention excavates, clones and identifies for the first time three flavin-dependent halogenase genes from bacteria such as Alteromonas macleodii and Lacimicrobium alkaliphilum, which have the activity of catalyzing the bromination of natural polyphenolic compounds. The flavin-dependent halogenase with the activity of catalyzing the bromination of natural polyphenolic compounds provided by the present invention has a wide substrate spectrum, excellent bromination catalytic activity, and good industrial application prospects. BRIEF DESCRIPTION OF THE DRAWINGS

[0018] Figure 1 Structural formulas of natural polyphenol compounds;

[0019] Figure 2 AmFDH5 catalyzes the trans -resveratrol reaction;

[0020] Figure 3 LaFDH2 / LaFDH5 catalyzes the trans-resveratrol reaction;

[0021] Figure 4 HPLC detection of resveratrol catalyzed by halogenases AmFDH5, LaFDH2 and LaFDH4. DETAILED DESCRIPTION

[0022] After extensive and in-depth research, the inventor unexpectedly discovered three flavin-dependent brominase genes with high bromination activity and a wide substrate spectrum for natural polyphenol compounds, thus providing a basis for developing excellent flavin-dependent halogenases for the production of brominated polyphenols. On this basis, the present invention was completed.

[0023] The following is a further description of the principles and features of the present invention. The examples listed are only used to explain the present invention and are not intended to limit the scope of protection of the present invention. In addition, the experimental methods used in the following examples are conventional methods in the art unless otherwise specified. The materials, reagents, etc. used in the following examples, unless otherwise specified, can all be obtained from commercial sources.

[0024] Example 1: Construction of heterologous expression vector plasmid in E. coli

[0025] The inventors have conducted a large number of experiments and unremitting explorations to dig out flavin-dependent halogenases in strains from many different sources. Through candidate gene cloning, heterologous expression, and catalytic activity analysis, they finally dug out, identified, and screened 3 flavin-dependent halogenase genes with catalytic polyphenol compound bromination activity from bacteria such as Alteromonas macleodii and Lacimicrobium alkaliphilum. The above-mentioned protease genes obtained by digging were connected to the pET28a vector respectively to obtain a recombinant plasmid. The constructed recombinant plasmid was transformed into Escherichia coli DH5α competent cells and coated on a solid LB plate containing 50 μg / mL kanamycin. A single colony was picked for culture and plasmid extraction to obtain a recombinant plasmid, and colony PCR was used to verify whether the recombinant plasmid was successfully constructed. Three flavin-dependent halogenases with the activity of catalyzing the bromination of polyphenolic compounds were successfully expressed, among which: the amino acid sequence of AmFDH5 is shown in SEQ ID No.1, the amino acid sequence of LaFDH2 is shown in SEQ ID No.2; and the amino acid sequence of LaFDH4 is shown in SEQ ID No.3.

[0026] At the same time, a recombinant plasmid with a tag is constructed. The present invention specifically constructs a recombinant plasmid with a histidine tag.

[0027] In view of the teachings of the present invention and the prior art, those skilled in the art should also understand that the above-mentioned protein having the activity of catalyzing the bromination of polyphenol compounds should also include a variant form in which one or more (usually 1-30, preferably 1-10, more preferably 1-6, and most preferably 1-3) amino acids of the protein shown in any of the amino acid sequences of SEQ ID No. 1-3 are deleted, inserted and / or substituted, which has the same or similar functions as SEQ ID No. 1-3, and one or more (usually within 20, preferably within 10, and more preferably within 6) amino acids are added to the C-terminus and / or N-terminus. For example, adding one or more amino acids to the C-terminus and / or N-terminus, such as a tag added for the convenience of separation, generally does not change the function of the resulting protein.

[0028] Example 2: Catalytic activity experiment of Fl-Hals

[0029] The halogenases AmFDH5, LaFDH2 and LaFDH4 had no bromination activity towards tryptophan substrates.

[0030] Halogenases AmFDH5, LaFDH2 and LaFDH4 require flavin reductase in the reaction, such as flavin reductase RebF reported in the prior art to provide FADH 2 , bromination of natural polyphenolic compounds. 600 20), in the presence of flavin and flavin reductase RebF, catalyze 0.25mM substrate reaction at 25°C, pH 7.4 for 10h, and then perform LC-MS analysis. The catalytic bromination activity is analyzed based on the mass spectrometry results and HPLC results, and the substrate conversion rate is calculated. The bromination activities of AmFDH5, LaFDH2 and LaFDH4 for common representative natural polyphenol compounds: sesamin, piceatannol, trans-resveratrol, quercetin, naringenin, epicatechin, apigenin, and soybean yellow are shown in Table 1. The structural formulas of common representative natural polyphenol compounds are shown in Figure 1 .

[0031] Table 1

[0032] AmFDH5 LaFDH2 LaFDH4 Trans-resveratrol 100% 100% 100% Sesamin 27% 24% 50% Piceatannol 100% 100% 100% Quercetin 23% 33% 40% Naringenin 42% 20% 32% Epicatechin 42% 22% 22% Apigenin 30% 23% 64% Daidzein 12% 8% 30%

[0033] HPLC detection of resveratrol catalyzed by halogenase AmFDH5, LaFDH2 and LaFDH4 Figure 4 As shown, NMR characterization of the resveratrol bromination products confirmed that AmFDH5 catalyzed the bromination of trans-resveratrol to produce 4-bromo-resveratrol and 3`-bromo-resveratrol; LaFDH2 or LaFDH4 catalyzed the bromination of trans-resveratrol to produce 4-bromo-resveratrol, as shown below.

[0034] The flavin-dependent halogenases AmFDH5, LaFDH2 and LaFDH4 of the present invention can selectively bromide trans-resveratrol at different positions.

[0035] As shown in SEQ ID No. 1, AmFDH5 catalyzes the bromination of trans-resveratrol to generate 4-bromoresveratrol and 3'-bromoresveratrol. Further, pure 4-bromoresveratrol and 3'-bromoresveratrol can be prepared by separation. The structures of 4-bromoresveratrol and 3'-bromoresveratrol were identified by nuclear magnetic resonance analysis. The reaction formula is as follows: Figure 2 shown.

[0036] LaFDH2 as shown in SEQ ID No.2 or LaFDH4 as shown in SEQ ID No.3 catalyzes the bromination of trans-resveratrol to generate 4-bromoresveratrol, and the structure thereof is 4-bromoresveratrol as determined by NMR analysis. Figure 3shown.

[0037] The flavin-dependent halogenases AmFDH5, LaFDH2 and LaFDH4 of the present invention all have bromination activity on the common representative natural polyphenol compounds tested, and the corresponding bromination products are determined by liquid chromatography-mass spectrometry analysis after catalyzing different substrates.

[0038] The activities of the halogenases AmFDH5, LaFDH2 and LaFDH4 with and without His tags on resveratrol were measured respectively, and it was found that the halogenases after adding tags did not affect the catalytic bromination function of the halogenases without tags, and the catalytic bromination activity did not fluctuate significantly compared with the halogenases without tags. For example, the catalytic bromination activity of the halogenases AmFDH5, LaFDH2 and LaFDH4 with His tags on resveratrol can be maintained at about 90%, 95% and 90% of the activities of the halogenases without tags, respectively.

[0039] The above description of the embodiments is to facilitate the understanding and use of the invention by those skilled in the art. It is obvious that those skilled in the art can easily make various modifications to these embodiments and apply the general principles described herein to other embodiments without creative work. Therefore, the present invention is not limited to the above embodiments, and improvements and modifications made by those skilled in the art based on the disclosure of the present invention without departing from the scope of the present invention should be within the scope of protection of the present invention.

Claims

1. Use of the following protein or an expression vector comprising a nucleotide sequence encoding the protein or a host cell capable of expressing the following protein in catalyzing the bromination of natural polyphenol compounds, wherein the protein is: (a) a protein as described in any one of the amino acid sequences in SEQ ID No.1-3, or (b) a protein having the function of the protein described in (a) formed by substitution, deletion or addition of one or more amino acid residues in any one of the amino acids in SEQ ID No.1-3.

2. The use according to claim 1, characterized in that: The natural polyphenol compounds include stilbenes, flavonoids and lignans.

3. The use according to claim 1, characterized in that: The natural polyphenol compounds include, but are not limited to, sesamin, piceatannol, trans-resveratrol, quercetin, naringenin, epicatechin, apigenin, and daidzein.

4. The use according to claim 1, characterized in that: When the natural polyphenol compound is trans-resveratrol, the protein shown in SEQ ID No. 1 catalyzes the bromination of trans-resveratrol to produce 4-bromo-resveratrol and 3'-bromo-resveratrol, and the protein shown in SEQ ID No. 2 or the protein shown in SEQ ID No. 3 catalyzes the bromination of resveratrol to produce 4-bromo-resveratrol.

5. The use according to claim 1, characterized in that: A tag sequence is added to the end of the amino acid sequence of the protein shown in (a) or (b) and the protein has the function of the protein described in (a).

6. The use according to claim 1, characterized in that: The application method comprises the following steps: in the presence of flavin and flavin reductase, catalyzing the bromination of natural polyphenol compounds to synthesize brominated natural polyphenol compounds.

Citation Information

Patent Citations

  • Flavonoid glycosyl transferase as well as coding gene and application thereof

    CN115927240A

Cited By

  • Method for efficiently synthesizing methyl 2-chloro-3-oxovalerate

    CN121575055A